| 968 | 5-[3-bromo-4-(dimethylamino)phenyl]-2,3,5,6-tetrahydro-2,2-dimethyl-benzo[A]phenanth-ridin-4(1H)-one |
| ALDOB | Aldolase B |
| ARE | Antioxidant response element |
| BPTES | Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-Yl)ethyl sulfide |
| BRAF | Proto-oncogene B-RAF |
| BSO | Buthionine sulfoximine |
| ccRCC | Clear cell renal cell carcinoma |
| CDKN2A | Cyclin-dependent kinase inhibitor 2A |
| CDKN2B | Cyclin-dependent kinase inhibitor 2B |
| chRCC | Chromophobe renal cell carcinoma |
| CRAF | Proto-oncogene C-RAF |
| CTLA-4 | Cytotoxic T lymphocyte-associated protein 4 |
| CUL3 | Cullin 3 |
| DCR | Disease control rate |
| DON | 6-diazo-5-oxo-l-norleucine |
| DUB | Deubiquitinating enzyme |
| EGFR | Epidermal growth factor receptor |
| EGLN | Egl-nine homolog |
| FAK | Focal adhesion kinase |
| FBP | Fructose 1,6-bisphosphate |
| FBP1 | Fructose 1,6-bisphosphatase 1 |
| FH | Fumarate hydratase |
| FLT3 | Fms-like tyrosine kinase 3 |
| G6PD | Glucose-6-phosphate dehydrogenase |
| GCL | Glutamate cysteine ligase |
| GCLC | Glutamate cysteine ligase catalytic subunit |
| GCLM | Glutamate cysteine ligase modulatory subunit |
| GGT | γ-glutamyl transferase |
| GGT1 | γ-glutamyl transferase 1 |
| GLS1 | Glutaminase 1 |
| GLS2 | Glutaminase 2 |
| GLUD | Glutamate dehydrogenase |
| GLUT1 | Glucose transporter type 1 |
| GPX | Glutathione peroxidase |
| GR | Glutathione reductase |
| GSH | Glutathione reduced form |
| GSS | Glutathione synthetase |
| GSSG | Glutathione oxidized form |
| GST | Glutathione S-transferase |
| HGF | Hepatocyte growth factor |
| HIF | Hypoxia inducible factor |
| KEAP1 | Kelch-like ECH-associated protein 1 |
| KIT | Tyrosine-protein kinase kit |
| MET | Proto-oncogene c-Met |
| MYC | MYC proto-oncogene |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NOX4 | NADPH oxidase 4 |
| NRAS | NRAS proto-oncogene, GTPase |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| ODD | Oxygen-dependent degradation |
| PC | Pyruvate carboxylase |
| PD-1 | Programmed cell death 1 |
| PD-L1 | Programmed cell death-ligand 1 |
| PDGFR | Platelet-derived growth factor receptor |
| PPP | Pentose phosphate pathway |
| pRCC | Papillary renal cell carcinoma |
| R5P | Ribose 5-phosphate |
| RCC | Renal cell carcinoma |
| RET | RET proto-oncogene |
| ROS | Reactive oxygen species |
| RTK | Receptor tyrosine kinase |
| SAH | S-adenosyl homocysteine |
| SAM | S-adenosyl methionine |
| SETD2 | Set domain-containing 2, histone lysine methyltransferase |
| SLC38A1 | Solute carrier family 38 member 1 |
| SLC7A11 | Solute carrier family 7 member 11 |
| TERT | Telomerase reverse transcriptase |
| TFE3 | Transcription factor E3 |
| TSC1 | Tuberous sclerosis 1 protein |
| TSC2 | Tuberous sclerosis 2 protein |
| VDAC1 | Voltage-dependent anion channel 1 |
| VDAC2 | Voltage-dependent anion channel 2 |
| VDAC3 | Voltage-dependent anion channel 3 |
| VEGF | Vascular endothelial growth factor |
| VEGFR | Vascular endothelial growth factor receptor |
| VHL | von Hippel-Lindau |